WeightWatchers stock rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'
WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The weight-loss company, previously championed by the likes of Oprah Winfrey, saw its stock spike this week after announcing that it will make copycats of Novo Nordisk's (NVO) Ozempic and Wegovy weight-loss drugs.
WeightWatchers to offer compounded GLP-1 weight-loss drugs
WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy.
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight management interventions that are underpinned by the comprehensive,
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its WeightWatchers Clinic members, expanding the accessibility of popular weight loss medications to its members at a more affordable price.
WeightWatchers stock pops on compounded GLP-1 weight-loss medication
Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it seeks to make the weight-management solution "accessible and affordable." Catalysts Hosts Seana Smith and Madison Mills report more on the story and how it can compete with GLP-1 weight-loss drugs like Novo Nordisk's (NVO) Ozempic and Eli Lilly's (LLY) Mounjaro.
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.
WeightWatchers is getting in on the off-brand weight loss drug game — and selling them cheap
WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in the industry.
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
Shares of WW International Inc., known as WeightWatchers, soared 18% Tuesday, after the weight-management company announced the addition of compounded GLP-1 obesity treatments to its offering. The new offering starts at $129.
WeightWatchers to offer compounded weight-loss drugs
WeightWatchers will begin selling compounded alternatives to certain weight-loss drugs that are experiencing shortages. Why it matters: Federal law allows companies to sell compounded versions of drugs that are on the FDA's shortages list — which has led to a surge of copycats to the newly popular class of GLP-1 injections.
WeightWatchers offers version of Ozempic, despite FDA concerns
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA say those versions come with risks.
WeightWatchers offering compounded version of Ozempic, despite concerns expressed by FDA
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
4029tv8h
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED ... It's part of a class of drugs known as GLP-1 ...
What's Going With WeightWatchers Stock On Wednesday?
WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...
clickondetroit.com2d
Low insurance coverage hampers access to weight-loss medications
In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...
The Business Journals14d
Weight Watchers CEO steps down
Her tenure encompassed the exploding popularity of GLP-1 weight loss drugs, a trend Weight Watchers hoped to capitalize by acquiring subscription telehealth platform Sequence (now ...
WeightWatchers Is Offering Knockoff Wegovy. The Market Is Already Crowded.
The compounding pharmacies that supply knockoff Wegovy can only legally make it as long as it remains on the Food and Drug ...